z-logo
Premium
HMGA 2 is associated with the aggressiveness of tongue squamous cell carcinoma
Author(s) -
Zhang H,
Tang Z,
Deng C,
He Y,
Wu F,
Liu O,
Hu C
Publication year - 2017
Publication title -
oral diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.953
H-Index - 87
eISSN - 1601-0825
pISSN - 1354-523X
DOI - 10.1111/odi.12608
Subject(s) - vimentin , gene knockdown , cancer research , cell migration , biology , metastasis , cell growth , epithelial–mesenchymal transition , cell , apoptosis , gentamicin protection assay , immunohistochemistry , cancer , immunology , biochemistry , genetics
Objective To analyze the effects of HMGA 2 on proliferation, invasion, and metastasis in tongue squamous cell carcinoma ( TSCC ). Methods HMGA 2 knockdown was performed in SCC 15 cell lines, and functional assay was applied to observe the effects on cell migration and invasion. Real‐time PCR , Western blotting, and immunohistochemistry ( IHC ) were also used to measure the expression of HMGA 2 and EMT markers. Results HMGA 2 expression was decreased after lentivirus infection. Functional assay showed that silence of HMGA 2 can inhibit the proliferation of SCC 15 cells and arrest the cells in G1/S phase. Moreover, knockdown of HMGA 2 enhanced apoptosis of SCC 15 cells. Wound‐healing assay and transwell assay indicated that knockdown of HMGA 2 significantly inhibited migration and invasion ability of SCC 15 cells. Expression detection suggested that HMGA 2 may be involved in the metastasis of SCC 15 cells by activating Twist family expression and inducing epithelial–mesenchymal transition ( EMT ) process. IHC analysis showed that HMGA 2 and vimentin were up‐regulated in TSCC tissues, while E‐cadherin was down‐regulated. Clinicopathological analysis indicated that expression of HMGA 2, E‐cadherin, and Vimentin were associated with recurrence of patients with TSCC . Conclusion Our findings demonstrated that HMGA 2 may promote malignant transformation of TSCC through EMT process and may be an independent prognosis biomarker for TSCC .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom